Final answer:
The patient who is receiving bleomycin (Blenoxane) therapy is most likely to exhibit increased respiratory rate and cough as symptoms.
Step-by-step explanation:
The patient who is receiving bleomycin (Blenoxane) therapy is most likely to exhibit increased respiratory rate and cough as a symptom. Bleomycin is a medication used in the treatment of various types of cancer, and it can cause lung toxicity as a side effect. Increased respiratory rate and cough are common signs of lung toxicity associated with bleomycin therapy.